Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins
Crossref DOI link: https://doi.org/10.1007/s10549-015-3624-8
Published Online: 2015-10-29
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Göbel, Andy
Browne, Andrew J.
Thiele, Stefanie
Rauner, Martina
Hofbauer, Lorenz C.
Rachner, Tilman D.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DE) (RA 2151/2-1, 3-1, HO 1875/15-1, 16-1)
Text and Data Mining valid from 2015-10-29